Renowned European NGOs, including Oxfam and Medecins Sans Frontieres, have thrown their weight behind the Indian generic drug industry, whose products have been seized by authorities in Europe alleging violation of patents.
"If the current EU trade policy remains, it will have a disastrous impact on the lives of millions... The Indian generic medicines industry, which exports two-thirds of its production to developing countries, could face restrictions," a joint declaration by Oxfam, Health Action International and Medicins Sans Frontieres said here.
The generic drugs are those on which the patents have lapsed and can be manufactured by anyone.
In his recent visit to New Delhi, Director General of Geneva-based World Intellectual Property Francis Gurry corroborated the point that generic drugs do not violate any patents.
Over the last one year, European authorities have seized over 18 generic consignments of Indian companies en route Latin America and Africa, alleging violation of patents.
The issue has repeatedly been taken up by the Commerce Ministry with the European authorities.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
